Introducing Cov-Check IgG / IgM test

Spark Diagnostics is pleased to introduce a Rapid Whole Blood Test for COVID-19IgG / IgM:  Cov-CHECK. The test is designed for the rapid qualitative detection of IgG and IgM antibodies to the 2019 novel Coronavirus (2019-nCoV,SARS-CoV-2) in human whole blood, serum or plasma. Cov-CHECK™ – COVID-19 IgG / IgM Test Device is a supplemental rapid screening tool for symptomatic or asymptomatic carriers of the virus.

CoV-Check Features

Test-Picture

Point-Of-Care COVID-19 Serological Screening Test

Just 2 ul finger prick Blood required

Quick Results in Just 15 minutes, saving critical time

Clinical Specificity: 99.0%

Clinical Sensitivity: 87.5% (vs. RT-PCR confirmed samples)

Accuracy: 96.8%

Complementary to RT-PCR testing

No special facilities needed; test can be used anywhere

Results are easy and clear to read

Can detect “silent infections”

No complex extraction procedure required

Not for diagnosis of active COVID-19 infection

Made in USA (CE Approved))

Clinical Significance

Clinical Significance RT-qPCR IgM IgG
Patient may be in the window period of infection
Patient may be in the window period of infection +
Patient may be in early stage of infection
Patient may be in early stage of infection + +
Patient is in active phase of infection
Patient is in active phase of infection + + +
Patient may be in the late or recurrent stage of infection
Patient may be in the late or recurrent stage of infection + +
Patient may be in the early stage of infetion. RT-qPCR result may befalse-negative
Patient may be in the early stage of infetion. RT-qPCR result may befalse-negative +
Patient may have had past infection and has recovered
Patient may have had past infection and has recovered +
Patient may be in the recovery stage of infection, or the RT-qPCR result may be false-negative
Patient may be in the recovery stage of infection, or the RT-qPCR result may be false-negative + +

Mississippi County Hospital System USA Validates Cov-Check™ COVID-19 IgG / IgM Rapid Test

Spark Diagnostics successfully conducted a Validation Study of our a Rapid Serology antibodies test with 95% sensitivity in majority of the Covid-19 (Coronavirus) positive patients.  Further, Cov-Check™ COVID-19 IgG / IgM  has received excellent reviews from our customers.